Pay in 4 interest-free payments of $6.92 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Based on publicly available FDA records of the warning letters issued in September 2025 and February/March 2026, Eden's name does not appear among the companies that received warning letters in those enforcement rounds
Clinical evidence supports it: The SEMALEAN study (2025) found a 15% reduction in visceral fat and an average of 12 kg total weight loss over six months
These hormones include testosterone, luteinizing hormone (LH), and gonadotropin-releasing hormone (GnRH)
specialist advice should be sought in clinical or trial settings
Buyers typically classify it within antidiabetic/GLP-1 receptor agonist category and may also manage it under metabolic therapy procurement lines depending on local formularies
According to Lilly, Retatrutide is not currently FDA-approved and is still being evaluated in clinical trials
US$ 23.21
US$ 21.73
US$ 21.06
US$ 22.23
